CYTK
Cytokinetics Inc.
stockNASDAQ
At CloseOct 21, 2026 3:59:55 PM EDT
62.88USD-1.673%(-1.07)1,080,526
CYTK News
Cytokinetics to Announce Third Quarter Results on November 4, 2026 · 
GlobeNewswire Inc.
Cytokinetics EVP Fady Malik sells over $224,000 in stock · 
Investing.com
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · GlobeNewswire Inc.
UBS cuts Cytokinetics stock price target on valuation, keeps Buy · Investing.com
Cytokinetics EVP Fady Malik sells $214,830 in company stock · Investing.com
Cytokinetics launches real-world study of heart drug MYQORZO · Investing.com
Cytokinetics CEO Robert Blum sells $490,949 in stock · Investing.com
Cytokinetics EVP Fady Malik sells $239k in company stock · Investing.com
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) · GlobeNewswire Inc.
Cytokinetics director Robert Landry sells $72,130 in shares · Investing.com
Cytokinetics CEO Blum’s trust sells $6.7m in company shares · Investing.com
Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook? · 
Zacks Investment Research